Compass Therapeutics (CMPX) Insider Trading & Ownership $3.60 -0.10 (-2.57%) As of 12:34 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Compass Therapeutics (NASDAQ:CMPX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage29.80%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$51.90KNumber OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$5.68M Get CMPX Insider Trade Alerts Want to know when executives and insiders are buying or selling Compass Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CMPX Insider Buying and Selling by Quarter Compass Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/27/2025Thomas J SchuetzCEOBuy10,000$2.11$21,100.00 4/9/2025Carl L GordonDirectorSell3,571,428$1.59$5,678,570.52 4/7/2025Jonathan AndermanInsiderBuy20,000$1.54$30,800.00 (Data available from 1/1/2013 forward) CMPX Insider Trading Activity - Frequently Asked Questions Who is on Compass Therapeutics' Insider Roster? The list of insiders at Compass Therapeutics includes Carl L Gordon, Jonathan Anderman, Orbimed Advisors Llc, Thomas J Schuetz, and Vered Bisker-Leib. Learn more on insiders at CMPX. What percentage of Compass Therapeutics stock is owned by insiders? 29.80% of Compass Therapeutics stock is owned by insiders. Learn more on CMPX's insider holdings. Which Compass Therapeutics insiders have been buying company stock? The following insiders have purchased CMPX shares in the last 24 months: Jonathan Anderman ($30,800.00), and Thomas J Schuetz ($21,100.00). How much insider buying is happening at Compass Therapeutics? Insiders have purchased a total of 30,000 CMPX shares in the last 24 months for a total of $51,900.00 bought. Which Compass Therapeutics insiders have been selling company stock? The following insider sold CMPX shares in the last 24 months: Carl L Gordon ($5,678,570.52). How much insider selling is happening at Compass Therapeutics? Insiders have sold a total of 3,571,428 Compass Therapeutics shares in the last 24 months for a total of $5,678,570.52 sold. Compass Therapeutics Key ExecutivesDr. Vered Bisker-Leib M.D. (Age 53)MBA, Ph.D., CEO & Director Compensation: $719kDr. Thomas J. Schuetz M.D. (Age 63)Ph.D., Co-Founder, President of Research & Development and Vice Chairman of the Board Compensation: $835.88kMr. Neil L. Lerner CPA (Age 57)Vice President of Finance Mr. Jonathan Anderman J.D.VP, Head of Legal & Corporate Secretary1 recent tradesAnna GiffordCommunications ManagerDr. Minori Rosales M.D. (Age 61)Ph.D., Senior VP & Head of Clinical Development Ms. Karin Herrera B.A.VP & Head of Clinical OperationsDr. James Kranz Ph.D.VP and Head of Chemistry Manufacturing & Controls More Insider Trading Tools from MarketBeat Related Companies RXRX Insider Trades DNLI Insider Trades ANIP Insider Trades ADPT Insider Trades DYN Insider Trades VERA Insider Trades SRPT Insider Trades APGE Insider Trades NTLA Insider Trades HROW Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Oklo Insiders Sell! Oh No! This Is Why Investors Shouldn’t WorryTop Insider Buys and Sells From September: Buy, Sell, or Hold?NuScale, Rocket Lab Face Heavy Insider Selling After Surges3 Small Caps That Insiders Are Buying $100 Million Buyback in Upwork Stock Follows a Strong Quarter This page (NASDAQ:CMPX) was last updated on 10/6/2025 by MarketBeat.com Staff From Our PartnersNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredArizona-made nanochips the new millionaire maker?George Gilder handed President Reagan the first microchip that helped create $6.5 trillion in wealth over the ...Banyan Hill Publishing | Sponsored"I'm risking my reputation on this"My prediction: Q4 2025 won't just be another seasonal crypto pump. It will be the quarter that sparks a crypto...Crypto 101 Media | SponsoredOctober 2025 Market Crash?Wall Street Legend Names #1 Stock [not NVDA] The greatest quantitative mind on Wall Street just revealed hi...Chaikin Analytics | SponsoredThe next wave of AI fortunes may come from NVIDIA’s secret supplier.Bloomberg says AI is a $50 trillion revolution. And at the center of it… isn't NVIDIA. It's a tiny suppl...Behind the Markets | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Compass Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Compass Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.